Evidence map›Paper›PMID 38027524›Full record

ReviewFrontiers in neuroscience2023

The use of hyperbaric oxygen for veterans with PTSD: basic physiology and current available clinical data.

Keren Doenyas-Barak, Ilan Kutz, Erez Lang, Rachel Merzbach, Rachel Lev Wiesel, Rahav Boussi-Gross, Shai Efrati

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Keren Doenyas-BarakSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Ilan KutzSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Erez LangSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Rachel MerzbachSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Rachel Lev WieselSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Rahav Boussi-GrossSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Shai EfratiSagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel.
Assaf Harofeh Medical Center · ILBar-Ilan University · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-traumatic stress disorder (PTSD) affects up to 30% of veterans returning from the combat zone. Unfortunately, a substantial proportion of them do not remit with the current available treatments and thus continue to experience long-term social, behavioral, and occupational dysfunction. Accumulating data implies that the long-standing unremitting symptoms are related to changes in brain activity and structure, mainly disruption in the frontolimbic circuit. Hence, repair of brain structure and restoration of function could be a potential aim of effective treatment. Hyperbaric oxygen therapy (HBOT) has been effective in treating disruptions of brain structure and functions such as stroke, traumatic brain injury, and fibromyalgia even years after the acute insult. These favorable HBOT brain effects may be related to recent protocols that emphasize frequent fluctuations in oxygen concentrations, which in turn contribute to gene expression alterations and metabolic changes that induce neuronal stem cell proliferation, mitochondrial multiplication, angiogenesis, and regulation of the inflammatory cascade. Recently, clinical findings have also demonstrated the beneficial effect of HBOT on veterans with treatment-resistant PTSD. Moderation of intrusive symptoms, avoidance, mood and cognitive symptoms, and hyperarousal were correlated with improved brain function and with diffusion tensor imaging-defined structural changes. This article reviews the current data on the regenerative biological effects of HBOT, and the ongoing research of its use for veterans with PTSD.

Indexed as

combat-associated PTSDhyperbaric oxygen therapyneuroplasticitypost-traumatic stress disordertreatment-resistant PTSD

Identifiers

PMID38027524
PMCPMC10630921
OpenAlexW4388263620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.